Dual activity against α-glucosidase and PTP1B for compounds 2c, 2g and 2h would probably result in synergistic effects to prevent hyperglycaemia, in turn, effectively improving insulin sensitization without increasing lipid metabolism and causing lipid accumulation in livers. The gene discussed is PTPN1; the disease is Hyperglycemia.